JanOne Management

Management criteria checks 3/4

JanOne's CEO is Tony Isaac, appointed in May 2016, has a tenure of 7.92 years. total yearly compensation is $817.71K, comprised of 75.5% salary and 24.5% bonuses, including company stock and options. directly owns 2.53% of the company’s shares, worth $1.11M. The average tenure of the management team and the board of directors is 5.5 years and 4.3 years respectively.

Key information

Tony Isaac

Chief executive officer

US$817.7k

Total compensation

CEO salary percentage	75.5%
CEO tenure	7.9yrs
CEO ownership	2.5%
Management average tenure	5.5yrs
Board average tenure	4.3yrs

Recent management updates

Shareholders May Be A Bit More Conservative With JanOne Inc.'s (NASDAQ:JAN) CEO Compensation For Now

Oct 03

Recent updates

JanOne Inc.'s (NASDAQ:JAN) Share Price Boosted 153% But Its Business Prospects Need A Lift Too

Mar 31

JanOne Inc. (NASDAQ:JAN) Stock Catapults 75% Though Its Price And Business Still Lag The Industry

Feb 14

Shareholders May Be A Bit More Conservative With JanOne Inc.'s (NASDAQ:JAN) CEO Compensation For Now

Oct 03

CEO Compensation Analysis

How has Tony Isaac's remuneration changed compared to JanOne's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 30 2023	US$818k	US$618k	-US$17m
Sep 30 2023	n/a	n/a	US$155k
Jul 01 2023	n/a	n/a	US$614k
Apr 01 2023	n/a	n/a	US$308k
Dec 31 2022	US$625k	US$550k	US$8m
Oct 01 2022	n/a	n/a	US$2m
Jul 02 2022	n/a	n/a	US$2m
Apr 02 2022	n/a	n/a	-US$1m
Jan 01 2022	n/a	n/a	-US$3m
Oct 02 2021	n/a	n/a	-US$6m
Jul 03 2021	n/a	n/a	-US$6m
Apr 03 2021	n/a	n/a	-US$6m
Jan 02 2021	US$534k	US$534k	-US$8m
Sep 26 2020	n/a	n/a	-US$12m
Jun 27 2020	n/a	n/a	-US$13m
Mar 28 2020	n/a	n/a	-US$12m
Dec 28 2019	US$571k	US$571k	-US$12m
Sep 28 2019	n/a	n/a	-US$7m
Jun 29 2019	n/a	n/a	-US$6m
Mar 30 2019	n/a	n/a	-US$6m
Dec 29 2018	US$805k	US$543k	-US$6m
Sep 29 2018	n/a	n/a	-US$2m
Jun 30 2018	n/a	n/a	-US$474k
Mar 31 2018	n/a	n/a	US$2m
Dec 30 2017	US$550k	US$550k	US$6m

Compensation vs Market: Tony's total compensation ($USD817.71K) is about average for companies of similar size in the US market ($USD675.31K).

Compensation vs Earnings: Tony's compensation has increased whilst the company is unprofitable.

CEO

Tony Isaac (69 yo)

7.9yrs

Tenure

US$817,709

Compensation

Mr. Tony Isaac is a Director at Live Ventures Inc. since December 12, 2011. He serves as Chief Executive Officer of JanOne Inc. (formerly known as Appliance Recycling Centers of America, Inc.) since May 20...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Tony Isaac	President	7.9yrs	US$817.71k	2.53% $ 1.1m
Virland Johnson	Chief Financial Officer	6.7yrs	US$349.35k	0.91% $ 400.9k
Tony Giordano	Chief Scientific Officer	4.3yrs	no data	no data
Douglas Flanagan	Chief Formulation Advisor	3.8yrs	no data	no data

5.5yrs

Average Tenure

Experienced Management: JAN's management team is seasoned and experienced (5.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Tony Isaac	President	8.9yrs	US$817.71k	2.53% $ 1.1m
Richard Butler	Independent Director	8.9yrs	US$30.00k	0.16% $ 71.4k
John Cooke	Member of Scientific Advisory Board	3.8yrs	no data	no data
Nicholas Goeders	Member of Scientific Advisory Board	2.8yrs	no data	no data
Christopher Kevil	Chair of Scientific Advisory Board	4.3yrs	no data	no data
Edgar Ross	Member of Scientific Advisory Board	3.8yrs	no data	no data
Nael Hajjar	Independent Director	5.7yrs	US$14.40k	no data
John Bitar	Independent Director	4.3yrs	US$18.00k	0.023% $ 10.2k
Joshua Beckman	Member of Scientific Advisory Board	no data	no data	no data

4.3yrs

Average Tenure

58.5yo

Average Age

Experienced Board: JAN's board of directors are considered experienced (4.3 years average tenure).

JanOne Management

Management criteria checks 3/4

Key information

Recent management updates

Shareholders May Be A Bit More Conservative With JanOne Inc.'s (NASDAQ:JAN) CEO Compensation For Now

JanOne Inc., Annual General Meeting, Oct 09, 2023

High number of new and inexperienced directors

JanOne Inc., Annual General Meeting, Nov 02, 2022

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

JanOne Inc.'s (NASDAQ:JAN) Share Price Boosted 153% But Its Business Prospects Need A Lift Too

JanOne Inc. announced delayed annual 10-K filing

JanOne Regains Compliance with Nasdaq’s Listing Requirements

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 93%

JanOne Inc. (NASDAQ:JAN) Stock Catapults 75% Though Its Price And Business Still Lag The Industry

New minor risk - Profit margin trend

New major risk - Shareholder dilution

New major risk - Share price stability

Shareholders May Be A Bit More Conservative With JanOne Inc.'s (NASDAQ:JAN) CEO Compensation For Now

JanOne Receives Non-Compliance Notice from the Nasdaq Stock Market

JanOne Inc., Annual General Meeting, Oct 09, 2023

New minor risk - Share price stability

New major risk - Earnings quality

Janone Inc. Files International Patent Application for Methods of Using Low Dose Naltrexone to Treat Chronic Pain

JanOne Inc. announced delayed 10-Q filing

Full year 2022 earnings released: EPS: US$1.14 (vs US$6.35 loss in FY 2021)

JanOne Received A Notice from the NASDAQ Stock Market

Third quarter 2022 earnings released: US$0.66 loss per share (vs US$0.34 loss in 3Q 2021)

High number of new and inexperienced directors

JanOne Inc., Annual General Meeting, Nov 02, 2022

JanOne Inc. (NasdaqCM:JAN) enter into a term sheet to acquire Soin Therapeutics LLC Soin Therapeutics LLC for $30 million.

JanOne to acquire Soin Therapeutics

Does JanOne (NASDAQ:JAN) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released: EPS: US$3.39 (vs US$2.07 loss in 2Q 2021)

JanOne Inc. Announces an Improved Formulation of JAN101

JanOne Inc. Announces the Issuance of U.S. Patent Covering A Method of Improving Nerve Function Using Jan101

First quarter 2022 earnings released: EPS: US$0.43 (vs US$0.26 in 1Q 2021)

High number of new and inexperienced directors

JanOne Receives Notice from Nasdaq for Not Complying with Listing Rules

Full year 2021 earnings released: US$6.35 loss per share (vs US$4.59 loss in FY 2020)

Health Check: How Prudently Does JanOne (NASDAQ:JAN) Use Debt?

Is JanOne (NASDAQ:JAN) Using Debt In A Risky Way?

Third quarter 2021 earnings released: US$0.34 loss per share (vs US$0.43 loss in 3Q 2020)

High number of new and inexperienced directors

Janone Janone Inc. Revises Its Development Strategy Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate Jan101

Janone Inc. Readies Clinical Supply of Lead Product Candidate Jan101 for Distribution to Phase 2B Trial Sites

JanOne Selects Regulatory Partner for Phase 2B Trial as Investigational Plan Is Prepared for FDA Filing

JanOne adds Nicholas Goeders to scientific advisory board

JanOne Announces Initiation of Phase 2b Peripheral Artery Disease Trial for Lead Product Candidate JAN101

JanOne advances toward initiation of mid-stage peripheral artery disease trial

Chief Financial Officer recently sold US$221k worth of stock

First quarter 2021 earnings released: EPS US$0.26 (vs US$1.33 loss in 1Q 2020)

Full year 2020 earnings released: US$4.59 loss per share (vs US$6.78 loss in FY 2019)

Virland Johnson entered into a definitive agreement to acquire substantially all assets and certain liabilities of ARCA Recycling, Inc. from JanOne Inc. (NasdaqCM:JAN) for $25 million.

JanOne Inc. has completed a Follow-on Equity Offering in the amount of $5.999994 million.

JanOne under pressure on pricing $6M stock offering

New 90-day high: US$5.47

New 90-day high: US$5.08

Third quarter 2020 earnings released: US$0.43 loss per share

New 90-day low: US$3.50

JanOne Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study

New 90-day high - US$5.86

Earnings released

New 90-day high - US$3.74

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age